Diagnostic Strategy for Suspected Pulmonary Embolism Based on 4PEPS
Key facts
- Who runs it
- University Hospital, Angers
- Where
- Belgium and France23 sites in 2 countriesChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 3,084 people enrolled
- Started
- 29 Nov 2023
- Ended
- 10 Nov 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- 4PEPS strategy
- Record updated
- 17 July 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Admission to an emergency department participating in the study
- Suspected PE due to thoracic symptoms (dyspnea, chest pain, or hemoptysis) and/or syncope without any other obvious explanation after clinical examination and possible additional first-line tests (ECG, chest X-ray, or routine lab work-up)
Who cannot take part
- Curative dose of anticoagulant in place for more than two days prior to inclusion
- Patient undergoing compulsory psychiatric treatment
- Age < 18 years
- Known result of a specific diagnostic imaging examination for PE (thoracic CT angiography, pulmonary scintigraphy, or venous ultrasound of the lower limbs)
- Hemodynamic instability (systolic blood pressure < 90 mmHg or more than 40 mmHg lower than usual for more than 15 min)
- Pregnant or parturient patient
- Patient in detention by judicial or administrative decision
- Patient placed under a legal protection measure
- Patient who objects to participating in the research (preliminary phase) or is unable to give free and informed consent (active phase)
This trial has no sites in United States.
It has sites in 2 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
The increased use of diagnostic imaging and especially computed tomography pulmonary angiography in patients suspected of pulmonary embolism (PE) is an important point of concerns.
Read full original descriptionShow less
The goal of this pragmatic cluster-randomized trial is to compare the diagnostic strategy based on the four-level pulmonary embolism probability score (4PEPS) and current practices.
The main questions it aims to answer is: "Does the diagnostic strategy based on 4PEPS significantly reduce the use of thoracic imaging without increasing the risk of serious adverse events as compared to current diagnostic practices?" Patients suspected of having PE in the participating emergency departments will be included and followed for 90 days. In ten centers, the emergency physicians will apply the 4PEPS strategy and in ten other centers, the emergency physicians will be free to do as they see fit. Researchers will compare the two groups of patients to see if the rate of diagnostic thoracic imaging tests and the rate of adverse events related to diagnostic strategies will differ.
The 2 groups in the trial
- Control group - current practicesNo study treatment, for comparison
The investigating physicians of the participating centers in the control group will be free to provide care as they see fit. However, a reminder of national and European guidelines for PE management will be given to them and they will have the recommendation to apply a validated strategy. To make it easier, the different scores will be included in the clinical help-decision support software called SPEED. Investigators will be asked to enter data about the included patients directly into SPEED, which will act as the study's electronic case report form (eCRF). A paper version of the CRF will also be available.
- Intervention group - 4PEPS strategyExisting treatment, for comparison
Physicians of the participating centers in the intervention group will have the recommendation to apply the 4PEPS strategy. To make it easier to apply, the 4PEPS score will be included in SPEED. Investigators will be asked to enter the information relating to patients included in the study directly into SPEED before performing any testing. Entering these data will enable the 4PEPS score to be calculated automatically and specific recommendations to be provided. A paper version of the CRF will also be available
Treatment: 4PEPS strategy
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Diagnostic Strategy for Suspected Pulmonary Embolism in Emergency Departments Based on the 4-Level Pulmonary Embolism Clinical Probability Score: SPEED&PEPS Trial
- Record updated
- 17 July 2026